Buprenorphine Transdermal System 47781-0419-04
Generic: Buprenorphine
- Manufacturer
- Alvogen Inc.
- Dosage Form
- Patch, Extended Release
- Route
- Transdermal
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- May 17, 2022
- Application
- ANDA207490
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine | 15 ug/h |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
47781-0419-04Selected4 POUCH in 1 CARTON (47781-419-04) / 1 PATCH in 1 POUCH (47781-419-11) / 168 h in 1 PATCH